Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, today announces that, due to the timing of the General Meeting and completion of the proposed Admission of both the Placing Shares and Subscription Shares on 23 April 2020, it will now announce its financial results for the 17 months ended 31 December 2019 on Wednesday, 6 May 2020.
The analyst briefing due to be held on Tuesday, 21 April 2020 will now be held by Alastair Smith, Chief Executive Officer, and Tony Gardiner, Chief Financial Officer, by webcast presentation, followed by a Q&A session at 09.30 hrs on Wednesday, 6 May 2020. Pre-registration is required for attendance to the call. To confirm attendance, please email email@example.com and you will be sent the link to join.
The shareholder and investor meeting that was due to be held on Wednesday, 22 April 2020 will now take place as a webcast presentation, followed by a Q&A session, at 17.00 hrs on Wednesday, 6 May 2020. You can register and access the shareholder and investor webcast via the following link:
Alastair Smith, Chief Executive Officer, and Tony Gardiner, Chief Financial Officer, will host the call and look forward to responding to questions from existing and prospective investors.